Natera (NASDAQ: NTRA) recently received a number of ratings updates from brokerages and research firms:

  • 8/12/2017 – Natera was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “sell” rating. According to Zacks, “Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. “
  • 8/10/2017 – Natera was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “buy” rating. They now have a $9.25 price target on the stock. According to Zacks, “Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. “
  • 8/10/2017 – Natera was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating.
  • 8/7/2017 – Natera had its price target lowered by analysts at Morgan Stanley from $18.00 to $13.00. They now have an “overweight” rating on the stock.
  • 8/1/2017 – Natera was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 7/25/2017 – Natera was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating.
  • 7/24/2017 – Natera was downgraded by analysts at ValuEngine from a “sell” rating to a “strong sell” rating.
  • 7/12/2017 – Natera was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. “

Natera, Inc. (NASDAQ:NTRA) opened at 11.19 on Monday. Natera, Inc. has a 52-week low of $7.35 and a 52-week high of $12.95. The company’s market cap is $595.57 million. The company’s 50 day moving average price is $9.95 and its 200 day moving average price is $9.62.

Natera (NASDAQ:NTRA) last issued its quarterly earnings results on Tuesday, August 8th. The medical research company reported ($0.52) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.52). The business had revenue of $53.60 million during the quarter, compared to analysts’ expectations of $50.57 million. Natera had a negative return on equity of 137.46% and a negative net margin of 62.64%. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.46) earnings per share. Equities research analysts anticipate that Natera, Inc. will post ($2.03) EPS for the current fiscal year.

Receive News & Stock Ratings for Natera Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc and related stocks with our FREE daily email newsletter.